Prelude Capital Management, LLC Ark Genomic Revolution ETF (De Transaction History
Prelude Capital Management, LLC
- $1.85 Billion
- Q1 2024
A detailed history of Prelude Capital Management, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Prelude Capital Management, LLC holds 6,600 shares of ARKG stock, worth $152,856. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,600Holding current value
$152,856% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ARKG
# of Institutions
318Shares Held
19.1MCall Options Held
1.49MPut Options Held
2.83M-
Main Management ETF Advisors, LLC San Francisco, CA2.69MShares$62.3 Million4.12% of portfolio
-
Morgan Stanley New York, NY1.96MShares$45.3 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.3MShares$30.2 Million0.01% of portfolio
-
Ubs Group Ag1.27MShares$29.4 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY1.13MShares$26.2 Million0.0% of portfolio